Cantor Fitzgerald Initiates Coverage On Novo Nordisk with Overweight Rating, Announces Price Target of $120
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has initiated coverage on Novo Nordisk (NYSE:NVO) with an Overweight rating and set a price target of $120 for the company's stock.
December 01, 2023 | 1:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novo Nordisk received an Overweight rating from Cantor Fitzgerald with a price target of $120, indicating a positive outlook on the stock.
The initiation of coverage by Cantor Fitzgerald with an Overweight rating and a high price target suggests a strong vote of confidence in Novo Nordisk's stock performance. This positive analyst outlook can often lead to a short-term increase in stock price as investors react to the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100